Nesprin 1 and 2 in cardiac structure, function, and disease

Nesprin 1 和 2 在心脏结构、功能和疾病中的作用

基本信息

  • 批准号:
    8774924
  • 负责人:
  • 金额:
    $ 38.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-01-01 至 2015-11-30
  • 项目状态:
    已结题

项目摘要

Summary Mutations in the outer nuclear membrane proteins Nesprin 1 and 2 may be involved in the pathogenesis of Emery-Dreifuss muscular dystrophy (EDMD)-like phenotypes, including cardiomyopathy and dilated cardiomyopathy (DCM). Nesprins belong to a newly discovered family of spectrin-repeat proteins, composed of four members. Nesprin 1 and 2 are believed to anchor nuclei to actin filaments, and are ubiquitously expressed. To investigate functions of Nesprin 1 and 2, we have generated floxed and global knockout mice of both Nesprin 1 and 2. Our studies reveal that Nesprin 2 global knockout mice are viable and have no obvious basal phenotype, whereas over half of Nesprin 1 global knockout (Nesprin 1-/-) mice die perinatally. Remaining Nesprin 1-/- survivors have reduced body weight before three months of age and compromised exercise capacity. Consistent with data from others, we have found 100% perinatal lethality in double knockout mice for Nesprin 1 and 2. Histological analyses of skeletal muscle in Nesprin 1-/- mice and Nesprin 1 and 2 double knockout mice revealed abnormal positioning of non-synaptic nuclei and the disappearance of clusters of synaptic nuclei. We also observed that Nesprin 1-/- mice display abnormal shape and positioning of cardiomyocyte nuclei. In addition, we observed upregulation of protein levels of SUN1, a Nesprin 1 binding partner and an inner nuclear membrane protein, in Nesprin 1-/- heart samples. This 5 year proposal is to investigate the role of Nesprin 1 and 2 in cardiac nuclear position, nuclear membrane structure, and cardiac function by analysis of mutant mice and cells derived from them. Our unique ability to genetically ablate Nesprins in mouse cardiomyocytes, combined with the ability to test molecular and physiological functions in the whole animal, isolated papillary muscles, and cultured cardiomyocytes, will provide novel information as to the function of Nesprins in cardiac structure, function and disease.
总结 外核膜蛋白Nesprin 1和2的突变可能参与了 Emery-Dreifuss肌营养不良症(EDMD)样表型,包括心肌病和扩张型 心肌病(DCM)。Nesprins属于一个新发现的血影蛋白重复蛋白家族,由 四名成员。据信,Nesprin 1和2将细胞核锚到肌动蛋白丝,并且普遍存在于细胞中。 表达。为了研究Nesprin 1和2的功能,我们已经产生了以下基因的floxed和全局敲除小鼠: Nesprin 1和2。我们的研究表明,Nesprin 2全基因敲除小鼠是可行的, 基础表型,而超过一半的Nesprin 1全基因敲除(Nesprin 1-/-)小鼠围产期死亡。剩余 Nesprin 1-/-幸存者在三个月大之前体重减轻,运动量减少 容量与其他人的数据一致,我们发现,在双基因敲除小鼠中, Nesprin 1和2。Nesprin 1-/-小鼠和Nesprin 1和2双表达小鼠骨骼肌的组织学分析 敲除小鼠显示非突触核定位异常, 突触核我们还观察到Nesprin 1-/-小鼠显示异常的形状和位置, 心肌细胞核此外,我们观察到SUN 1蛋白水平的上调,SUN 1是一种Nesprin 1结合蛋白, 伴侣和内核膜蛋白,在Nesprin 1-/-心脏样本。这五年的计划是 研究Nesprin 1和2在心脏核位置、核膜结构和心脏功能中的作用。 通过分析突变小鼠及其衍生细胞的功能。我们独特的基因消融能力 Nesprins在小鼠心肌细胞中的作用,结合在心肌细胞中测试分子和生理功能的能力, 整个动物,分离的乳头肌和培养的心肌细胞,将提供新的信息, Nesprins在心脏结构、功能和疾病中的作用。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Generation and Characterization of a Tissue-Specific Centrosome Indicator Mouse Line.
  • DOI:
    10.1002/dvg.22937
  • 发表时间:
    2016-05
  • 期刊:
  • 影响因子:
    1.5
  • 作者:
    Hirai, Maretoshi;Chen, Ju;Evans, Sylvia M.
  • 通讯作者:
    Evans, Sylvia M.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ju Chen其他文献

Ju Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ju Chen', 18)}}的其他基金

ATF4 a Novel Regulator of Cardiac Development
ATF4 心脏发育的新型调节剂
  • 批准号:
    10657081
  • 财政年份:
    2023
  • 资助金额:
    $ 38.17万
  • 项目类别:
Novel function of a mitochondria phosphatase in cardiac development
线粒体磷酸酶在心脏发育中的新功能
  • 批准号:
    10436945
  • 财政年份:
    2021
  • 资助金额:
    $ 38.17万
  • 项目类别:
Protein Kinase Novel 2 (PKN2) in heart
心脏中的蛋白激酶 Novel 2 (PKN2)
  • 批准号:
    10322445
  • 财政年份:
    2021
  • 资助金额:
    $ 38.17万
  • 项目类别:
Nuclear envelope protein LEMD2 in heart
心脏中的核膜蛋白 LEMD2
  • 批准号:
    10278926
  • 财政年份:
    2021
  • 资助金额:
    $ 38.17万
  • 项目类别:
Protein Kinase Novel 2 (PKN2) in heart
心脏中的蛋白激酶 Novel 2 (PKN2)
  • 批准号:
    10548141
  • 财政年份:
    2021
  • 资助金额:
    $ 38.17万
  • 项目类别:
Nuclear envelope protein LEMD2 in heart
心脏中的核膜蛋白 LEMD2
  • 批准号:
    10662287
  • 财政年份:
    2021
  • 资助金额:
    $ 38.17万
  • 项目类别:
Novel function of a mitochondria phosphatase in cardiac development
线粒体磷酸酶在心脏发育中的新功能
  • 批准号:
    10181409
  • 财政年份:
    2021
  • 资助金额:
    $ 38.17万
  • 项目类别:
Novel function of a mitochondria phosphatase in cardiac development
线粒体磷酸酶在心脏发育中的新功能
  • 批准号:
    10687847
  • 财政年份:
    2021
  • 资助金额:
    $ 38.17万
  • 项目类别:
Nuclear envelope protein LEMD2 in heart
心脏中的核膜蛋白 LEMD2
  • 批准号:
    10463758
  • 财政年份:
    2021
  • 资助金额:
    $ 38.17万
  • 项目类别:
PRDM16 in cardiac development
PRDM16 在心脏发育中的作用
  • 批准号:
    10025986
  • 财政年份:
    2020
  • 资助金额:
    $ 38.17万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.17万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.17万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了